Research output per year
Research output per year
Search results
-
2022
Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19
Tran, F., Harris, D. M. M., Scharmacher, A., Graßhoff, H., Sterner, K., Schinke, S., Käding, N., Humrich, J. Y., Cabral-Marques, O., Bernardes, J. P., Mishra, N., Bahmer, T., Franzenburg, J., Hoyer, B. F., Glück, A., Guggeis, M., Ossysek, A., Küller, A., Frank, D., Lange, C., & 12 others, 2022, In: ERJ Open Research. 8, 4Research output: Journal Articles › Letters › peer-review
2 Citations (Scopus) -
2019
Evaluation of retinal microvascular perfusion in systemic sclerosis: A case-control study
Rothe, M., Rommel, F., Klapa, S., Humrich, J. Y., Nieberding, R., Lange, T., Sochurek, J. A. M., Plöttner, P., Grisanti, S., Riemekasten, G. & Ranjbar, M., 01.06.2019, In: Annals of the Rheumatic Diseases. 78, 6, p. 857-858 2 p.Research output: Journal Articles › Letters › peer-review
20 Citations (Scopus) -
Low-dose IL-2 for patients with systemic lupus erythematosus – Authors' reply
Humrich, J. Y. & Riemekasten, G., 12.2019, In: The Lancet Rheumatology. 1, 4, p. e203-e204Research output: Journal Articles › Letters › peer-review
-
2018
Detection of anti-neutrophil cytoplasmic and antinuclear autoantibodies favouring misdiagnoses in 5 cases of Erdheim-Chester disease
Ozden, F., Schinke, S., Thorns, C., Eckey, T., Dalhoff, K., Münte, T. F., Tronnier, V., Humrich, J. Y., Riemekasten, G. & Lamprecht, P., 01.01.2018, In: Clinical and Experimental Rheumatology. 36, p. S176Research output: Journal Articles › Letters › peer-review
1 Citation (Scopus) -
Diagnosis of deficiency of adenosine deaminase 2 with early onset polyarteritis nodosa in an adult patient with a novel compound heterozygous CECR1 mutation
Lamprecht, P., Humrich, J. Y., Diebold, I. & Riemekasten, G., 2018, In: Clinical and Experimental Rheumatology. 36, p. S177Research output: Journal Articles › Letters › peer-review
5 Citations (Scopus) -
2017
Low-dose IL-2 therapy-a complex scenario that remains to be further explored
Humrich, J. Y. & Riemekasten, G., 01.06.2017, In: Nature Reviews Rheumatology. 13, 6, p. 386 1 p.Research output: Journal Articles › Letters › peer-review
4 Citations (Scopus) -
2015
Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE
Humrich, J. Y., Spee-Mayer, C. V., Siegert, E., Alexander, T., Hiepe, F., Radbruch, A., Burmester, G. R. & Riemekasten, G., 01.04.2015, In: Annals of the Rheumatic Diseases. 74, 4, p. 791-792 2 p.Research output: Journal Articles › Letters › peer-review
97 Citations (Scopus) -
2011
The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: An open-label study
Becker, M. O., Brückner, C., Scherer, H. U., Wassermann, N., Humrich, J. Y., Hanitsch, L. G., Schneider, U., Kawald, A., Hanke, K., Burmester, G. R. & Riemekasten, G., 07.2011, In: Annals of the Rheumatic Diseases. 70, 7, p. 1340-1341 2 p.Research output: Journal Articles › Letters › peer-review
27 Citations (Scopus)